Dexcom raises 2025 revenue target to $4.6-5.1B, operating margin to 21%

DEXCOM INC

2025 revenue target raised to ~$4.6-5.1B from prior $4.0-4.5B.
Non-GAAP operating profit margin target raised to 21% (from 20%).
Adjusted EBITDA margin target raised to 31% (from 30%).
Non-GAAP gross profit margin target unchanged at 65%.
CEO Kevin Sayer cites strong performance and efficient business model.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.